Thorne HealthTech, Inc. (“Thorne HealthTech” or “Thorne”) (NASDAQ:THRN), a leader in developing innovative solutions for a personalized approach to health and well-being, today relaunched its Gut Health Test with the inclusion of its patent-pending Microbiome Wipe, a first-to-market approach to microbiome testing. Thorne’s Microbiome Wipe revolutionizes the user experience of microbiome testing by eliminating inconvenient stool sampling that often leads users to either postpone the test or not take it at all.
U.S. Department Of Energy Extends Fluor-led Savannah River Site Management And Operating Contract Through September 2027; Total Reimbursable Contract Value Is $12B For 5 Years, And Fluor Will Book Its 4-Year, $4.5B Portion In Q3
Fluor Corporation (NYSE:FLR) announced today that the U.S. Department of Energy (DOE) has extended the Fluor-led Savannah River Nuclear Solutions, LLC (SRNS) management and operating contract at the Savannah River
